Temporary support for acute liver failure

Journal of Clinical Gastroenterology

Volumn 35, Issue 4, 2002, Pages 335-344

  Rajvanshi, Pankaj ^a   Larson, Anne M ^a   Kowdley, Kris V ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Acute liver failure; Bioartificial liver; Fulminant hepatic failure; Liver assist device; Liver support

Indexed keywords

ALGORITHM; ARTICLE; HEMODIALYSIS; HEMOFILTRATION; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; MEDLINE; PATIENT CARE; PLASMAPHERESIS; PRIORITY JOURNAL;

HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; SORPTION DETOXIFICATION; SURVIVAL RATE; TIME FACTORS;

EID: 0036784481     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200210000-00011     Document Type: Article

References (69)

1. Trey C, Davidson CS. The management of fulminant hepatic disease. In: Popper, Scahffner, eds. Progress in liver disease, Vol. 3. New York: Grune and Stratton, 1970.
2. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-5.
3. Hoofnagle JH, Carithers RL, Shapiro C, et al. Fulminant hepatic failure: summary of a workshop. Hepatology 1995;21:240.
4. O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-45.
5. Ritt DJ, Whelan G, Werner D, et al. Acute hepatic necrosis with stupor or coma. Medicine 1969;48:151-72.
6. Trey C, Lipworth L, Chalmers TC, et al. Fulminant hepatic failure: presumable contribution to halothane. N Engl J Med 1968;279:798-801.
7. Shakil AO, Kramer D, Mazariegos GV, et al. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transplantation 2000;6:163-9.
8. Lee W. The Acute Liver Failure Study Group. Personal communication.
9. Williams R. Classification and clinical syndromes of acute liver failure. In: Lee, Williams, eds. Acute liver failure. 1st ed. Cambridge: Cambridge University Press, 1997.
10. Atillasoy E, Berk P. Extracorporeal liver support: historical background and critical analysis. In: Lee, Williams, eds. Acute liver failure, 1st ed. Cambridge: Cambridge University Press, 1997.
11. Peltekian K, Levy G. Role of cytokines and immune mechanisms in acute liver failure. In: Lee, Williams. eds. Acute liver failure, 1st ed. Cambridge: Cambridge University Press, 1997.
12. Lee C, Tink A. Exchange transfusion in hepatic coma: report of a case. Med J Aust 1958;1:40-2.
13. Trey C, Burns D, Saunders S. Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 1966;274:473-81.
14. Burnell JM, Dawborn JK, Epstein RB, et al. Acute hepatic coma treated by cross-circulation or exchange transfusion. N Engl J Med 1967:276: 935-43.
15. Lepore MJ, Stutman LJ, Bonanno CA, et al. Plasmapheresis with plasma exchange in hepatic coma: II. Fulminant viral hepatitis as a systemic disease. Arch Int Med 1972;129:900-7.
16. Buckner CD, Donohue RM, Burnell JM, et al. Plasma exchange in patients with fulminant hepatic failure. Arch Int Med 1973;132:487-92.
17. Winikoff S, Glassman MS, Spivak W. Plasmapheresis in a patient with hepatic failure awaiting liver transplantation. J Pediatr 1985;107:547-9.
18. Freeman JG, Matthewson K, Record CO. Plasmapheresis in acute liver failure. Int J Artif Organs 1986;9:433-8.
19. Munoz SJ, Ballas SK, Moritz MJ, et al. Perioperative management of fulminant and subfulminant hepatic failure with therapeutic plasmapheresis. Transplant Proc 1989;21:3535-6.
20. Kondrup J, Almdal T, Vilstrup H, et al. High volume plasma exchange in fulminant hepatic failure. Int J Artif Organs 1992;15:669-76.
21. Saibara T, Maeda T, Onishi S, et al. Plasma exchange and arterial blood ketone body ratio in patients with acute hepatic failure. J Hepatology 1994;20:617-22.
22. Larsen FS, Hansen BA, Jorgensen LG, et al. High-volume plasmapheresis and acute liver transplantation in fulminant hepatic failure. Transplant Proc 1994;26: 1788.
23. Tygstrup N, Larsen FS, Hansen BA. Treatment of acute liver failure by high volume plasmapheresis. In: Lee. Williams, eds. Acute liver failure, 1st ed. Cambridge: Cambridge University Press, 1997.
24. Yoshiba M, Inoue K, Sekiyama K, et al. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs 1996; 20:1169-71.
25. Okamoto K, Kurose M, Ikuta Y, et al. Prolonged artificial liver support in a child with fulminant hepatic failure. ASAIO J 1996;42:233-5.
26. Matsubara S, Okabe K, Ouchi K, et al. continuous removal of middle molecules by hemofiltration in patients with acute liver failure. Crit Care Med 1990;18: 1331-8.
27. Matsubara S, Okabe K, Ouchi K, et al. Temporary metabolic support by extracorporeal blood therapy for liver failure after surgery. ASAIO Trans 1988;34: 266-9.
28. Losgen H, Neumann E, Eisenbach G, et al. Correction of increased plasma amino acid levels by dialysis with amino-acid-electrolyte-glucose solutions. In: Brunner. Schmidt. eds. Artificial liver support. New York: Springer-Verlag, 1981.
29. Denis J, Opolon P, Nusinovici V, et al. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut 1978;19:787-93.
30. Gimson AES, Braude S, Mellon PJ, et al. Earlier charcoal hemoperfusion in fulminant hepatic failure. Lancet 1982;11:681-3.
31. O'Grady JG, Gimson AES, O'Brien CJ, et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-92.
32. Ash SR, Blake DE, Carr DJ, et al. Push-pull sorbent based pheresis for treatment of acute hepatic failure: the Biologic-detoxifier/plasma filter system. ASAIO J 1998;44:129-39.
33. Ash SR, Blake DE, Carr DJ, et al. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the Biologic-DT). Int J Artif Organs 1992; 15:151-61.
34. Hughes RD, Pucknell A, Routley D, et al. Evaluation of the Biologic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure. Int J Artif Organs 1994;17:657-62.
35. Wilkinson AH, Ash SR, Nissenson AR. Hemodiabsorption in treatment of hepatic failure. J Transplant Coord 1998;8:43-50.
36. Ellis AJ, Hughes RD, Nicholl D, et al. Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the Biologic-DT. Int J Artificial Organs 1999;22:27-34.
37. Ash SR. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif Organs 1994;18:355-62.
38. Stange J, Mitzner S. A carrier-mediated transport of toxins in a hybrid membrane: safety barrier between a patients blood and a bioartificial liver. Int J Artif Organs 1996;19:677-91.
39. Stange J, Mitzner SR, Risler T, et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999;23:319-30.
40. Mitzner SR, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transplantation 2000;6:277-86.
41. Eiseman B, Liem DS, Raffucci F. Heterologous liver perfusion in treatment of hepatic failure. Ann Surg 1965;162:329-45.
42. Abouna GM, Cook JS, Fisher LM, et al. Treatment of acute hepatic coma by ex vivo baboon and human liver perfusions. Surgery 1972;71:537-46.
43. Abouna GM, Fisher LM, Still WJ, et al. Acute hepatic coma successfully treated by extracorporeal baboon liver perfusions. BMJ 1972;1:23-5.
44. Lempinen M, Collan Y, Sivula A, et al. Pig liver perfusion: extracorporeal pig-liver perfusion in a patient with acute liver failure. Scand J Gastroenterol 1971;6:377-83.
45. Beveridge J. Pig liver perfusion and hepatic coma. Med J Aust 1968;23:510.
46. Abouna GM. Extracorporeal liver perfusion using a new perfusion chamber. Lancet 1968;7:1216-8.
47. Prabhoo SP, James IM, Ajdukiewicz A, et al. Extracorporeal pig-liver perfusion in treatment of hepatic coma due to fulminant hepatitis. Lancet 1971;1:659-65.
48. Chari RS, Collins BH, Magee JC, et al. Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med 1994;331:234-7.
49. Fox IJ, Langnas AN, Fristoe LW, et al. Successful application of extracorporeal liver perfusion: a technology whose time has come. Am J Gastroenterol 1993; 88:1876-81.
50. LeTissier P, Stoye JP, Takeuchi Y, et al. Two sets of human-tropic pig retrovirus. Nature 1997;389:681-2.
51. Margulis MS, Erikhumov EA, Andreiman LA, et al. Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency. Resuscitation 1989;18:85-94.
52. Watanabe FD, Mullon CJ-P, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure: a phase I clinical trial. Ann Surg 1997;225:484-94.
53. Detry O, Arkadopoulos N, Ting P, et al. Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure. Am Surg 1999; 65:934-8.
54. Sussman NL, Gislason GT, Conlin CA, et al. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs 1994; 15:390-6.
55. Ellis AJ, Hughes RD, Wendon JA, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996;24:1446-51.
56. Gerlach JC, Encke J, Hole O, et al. Hepatocyte culture between 3-dimensionally arranged biomatrix-coated independent artificial capillary systems and sinusoidal endothelial cell co-culture compartments. Int J Artif Organs 1994;17:301-6.
57. Riordan SM, Williams R. Extracorporeal support and hepatocyte transplantation in acute liver failure and cirrhosis. J Gastroenterol Hepatol 1999;14:757-70.
58. Mito M, Kusano M. Hepatocyte transplantation in man. Cell Transplant 1993; 2:65-74.
59. Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998;338: 1422-6.
60. Habibullah CM, Syed IH, Qamar A, et al. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 1994;58:951-77.
61. Strom SC, Fisher RA, Thompson MT, et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997;63:559-69.
62. Gupta S, Vemuru RP, Lee C-D, et al. Hepatocytes exhibit superior transgene expression after transplantation into liver and spleen compared with peritoneal cavity or dorsal fat pad: implications for hepatic gene therapy. Hum Gene Ther 1994;5:959-67.
63. Bilir BM, Kumpe D, Krysl J, et al. Hepatocyte transplantation (HT) in patients with liver cirrhosis [abstract]. Gastroenterology 1998;114:A1212.
64. Bilir BM, Guinette D, Karrer F, et al. Hepatocyte transplantation in acute liver failure. Liver Transplantation 2000;6:32-40.
65. Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Serum Liver Dis 1999;19:39-48.
66. Gunning K, Rowan K. Outcome data and scoring systems. BMJ 1999;319:241-4.
67. Mitchell I, Bihari D, Chang R, et al. Earlier identification of patients at risk from acetaminophen-induced acute liver failure. Crit Care Med 1998;26:279-84.
68. Ostapowicz G, Bass N, Crippin JS, et al. Comparison of APACHE II scores with King's criteria in predicting the outcome of acute liver failure [abstract]. Hepatology 1999;30:A168.
69. Rumack BH, Matthews H. Acetaminophen poisoning and toxicity. Pediatrics 1975;55:871-6.